Brief Report

Onychomycosis in Immunosuppressed Children Receiving Chemotherapy

  1. Maria Teresa García-Romero M.D.1,*,
  2. Enrique Lopez-Aguilar M.D.2,
  3. Roberto Arenas M.D.3

Article first published online: 29 OCT 2012

DOI: 10.1111/pde.12030

Additional Information

How to Cite

Teresa García-Romero, M., Lopez-Aguilar, E. and Arenas, R. (2012), Onychomycosis in Immunosuppressed Children Receiving Chemotherapy. Pediatric Dermatology. doi: 10.1111/pde.12030

Author Information

  1. 1

    Department of Dermatology, Hospital General Dr. Manuel Gea González, Mexico City, Mexico

  2. 2

    Department of Oncology, Hospital de Pediatría, Centro Médico Nacional Siglo XXI Instituto Mexicano del Seguro Social, Mexico City, Mexico

  3. 3

    Mycology Section, Hospital General Dr. Manuel Gea González, Mexico City, Mexico

* Address correspondence to Maria Teresa García-Romero, M.D., Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Sección XVI, México City 14080, Mexico, or e-mail: teregarro@gmail.com

Publication History

  1. Article first published online: 29 OCT 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (75K)

Abstract

Onychomycosis in children has a low incidence worldwide; certain conditions such as immunosuppression have been described as risk factors for it. We studied 72 children receiving chemotherapy for different neoplasms to determine the frequency of onychomycosis. Only one patient had white superficial onychomycosis from Trichophyton rubrum, a frequency of 1.3%, not different from that reported in healthy patients.

View Full Article (HTML) Get PDF (75K)